Cost of revenue increased 37.0%
Cost of revenue changed +37.0% from the comparable as-filed period.
$20.3M→$27.8M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →KNSA financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Research & development increased 35.7%
Research & development changed +35.7% from the comparable as-filed period.
$24.2M→$32.8M2 prior comparisons
Gross margin moved 149 bp higher
Gross margin changed +149 basis points from the comparable as-filed period.
88.80%→90.29%2 prior comparisons
Stock-based compensation increased 28.8%
Stock-based compensation changed +28.8% from the comparable as-filed period.
$10.1M→$13.1M2 prior comparisons
Capital expenditure decreased 73.2%
Capital expenditure changed -73.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$671,000→$180,0002 prior comparisons
Working capital / assets moved 737 bp higher
Working capital / assets changed +737 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
49.41%→56.78%4 prior comparisons
Receivables / revenue moved 1785 bp lower
Receivables / revenue changed -1785 basis points from the comparable as-filed period.
28.61%→10.76%2 prior comparisons
Operating cash-flow margin moved 199 bp lower
Operating cash-flow margin changed -199 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
18.62%→16.63%2 prior comparisons
Free-cash-flow margin moved 169 bp lower
Free-cash-flow margin changed -169 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
18.25%→16.56%2 prior comparisons
R&D / revenue moved 190 bp lower
R&D / revenue changed -190 basis points from the comparable as-filed period.
13.36%→11.46%2 prior comparisons
SBC / revenue moved 104 bp lower
SBC / revenue changed -104 basis points from the comparable as-filed period.
5.61%→4.57%2 prior comparisons
Capex / revenue moved 31 bp lower
Capex / revenue changed -31 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.37%→0.06%2 prior comparisons
Current ratio increased 1.6%
Current ratio changed +1.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
3.85→3.914 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.